All News
Advertisement
Advertisement
Click the title above to open the Pharmaceutical Executive May 2018 issue in an interactive PDF format.
Insights from Partnering with IDNs: Biopharma Strategy Summit.
Advertisement
This article discusses the supply chain benefits of pharma companies distributing from South Florida.
Advertisement
This op-ed discusses the varying skills that business leaders should look at in scientists when thinking about talent for the lab and the executive suite.
Leela Barham reviews the Institute for Clinical Effectiveness Review's announced pilot program, which allow manufacturers to scrutinize executable versions of draft cost-effectiveness models.
Click the title above to open the Pharmaceutical Executive April 2018 issue in an interactive PDF format.
In terms of important clinical benefits and outcomes, modern biotech products have rarely shown the advantages of older generations of drugs, writes Bagrat Lalayan.
Click the title above to open the Pharmaceutical Executive March 2018 issue in an interactive PDF format.
Advertisement
Advertisement
Trending on PharmExec
1
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
2
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer
3
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
4
FDA Announces New Biosimilar-Targeted Draft Guidance
5
